NeuroVive has signed an agreement with the European Brain Injury Consortium to conduct a European multi-center Phase 2/3 clinical trial of NeuroSTAT for neuroprotection in patients with traumatic brain injury.
Salix Pharmaceuticals Ltd. confirmed that the Food and Drug Administration wants more information about Salix's irritable bowel syndrome treatment Xifaxan, and is not ready to grant a new marketing approval.
AstraZeneca PLC and Bristol-Myers Squibb Co. say the U.S. Food and Drug Administration has accepted for review a new drug application for diabetes drug dapagliflozin.
Lycera Corporation has entered into an exclusive research collaboration with Merck to discover, develop and commercialize small molecules that target T-helper 17 (Th17) cells, key mediators of inflammation.
France's Sanofi-Aventis SA says it will extend its cash buyout offer for Genzyme until next month, as part of its agreed $20.1 billion takeover of the U.S.-based specialty drugmaker.
Oracle announced Oracle Health Sciences Central Coding Release 3.0, a Web-based clinical trial data coding and dictionary management that promotes greater productivity for clinical trial teams.
Andor Technology plc launched the TuCam adapter for simultaneous two camera imaging.
Borrowing a page from modern manufacturing, scientists from the Florida campus of The Scripps Research Institute have built a microscopic assembly line that mass produces synthetic cell-like compartments.
New research has identified a small subset of normal white blood cells in the body that gives rise to a rare incurable form of leukemia.
Symphogen has been granted a U.S. patent for Sym004 as well as other antibody compositions containing at least two distinct anti-EGFR antibodies having certain binding characteristics.
Pfizer Inc. announced that the ORAL Sync Phase 3 study of tofacitinib, an investigational, novel, oral JAK inhibitor, being studied in moderate-to-severe rheumatoid arthritis, met its primary endpoints.
RainDance Technologies, Inc., and 454 Life Sciences announced a collaboration for the development and commercialization of a targeted next-generation sequencing (NGS) solution for the investigation of drug absorption, distribution, metabolism, and excretion (ADME).
GE Healthcare announced preliminary data from its ongoing structural cardiomyocyte biomarker collaboration with Genentech at the 50th Annual Meeting of The Society of Toxicology (SOT) in Washington D.C.
Japan has temporarily stopped using vaccines from U.S. drugmaker Pfizer Inc. and Sanofi-Aventis SA of France while it investigates the deaths of four children who were inoculated, the health ministry said.